DIFLUPREDNATE OPHTHALMIC

DIFLUPREDNATE OPHTHALMIC was reported 886 times

DIFLUPREDNATE OPHTHALMIC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OESOPHAGEAL MANOMETRY 1 0.2500
1 OCULAR SURFACE STEM CELL TRANSPLANT REJECTION 2 0.2222
2 INFECTIVE KERATITIS 4 0.0563
3 CORNEAL LACERATION 1 0.0556
4 INFECTIOUS CRYSTALLINE KERATOPATHY 2 0.0541
5 IRON BINDING CAPACITY UNSATURATED DECREASED 1 0.0500
6 CORNEAL GRAFT FAILURE 1 0.0435
7 VIRAL UVEITIS 4 0.0412
8 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 3 0.0411
9 CONJUNCTIVAL DEFECT 1 0.0385
10 CORNEAL TOXICITY 4 0.0360
11 RETINAL OCCLUSIVE VASCULITIS 8 0.0357
12 INFECTIVE SCLERITIS 3 0.0333
13 RETINITIS VIRAL 4 0.0331
14 NEMATODIASIS 1 0.0294
15 SCLEROMALACIA 2 0.0290
16 DEPILATION 1 0.0286
17 ARTHRITIS FUNGAL 2 0.0278
18 GASTROINTESTINAL STOMA NECROSIS 1 0.0263
19 GRANULOCYTOSIS 5 0.0255
20 CYTOMEGALOVIRUS GASTROENTERITIS 5 0.0231
21 PSEUDOPHAKIA 2 0.0230
22 FUSOBACTERIUM INFECTION 2 0.0171
23 BULLOUS IMPETIGO 1 0.0167
24 CYTOMEGALOVIRUS OESOPHAGITIS 6 0.0163
25 ACQUIRED EPIDERMOLYSIS BULLOSA 2 0.0163
26 JUVENILE MYOCLONIC EPILEPSY 1 0.0159
27 BACTERIAL ENDOPHTHALMITIS 4 0.0150
28 CORNEAL ENDOTHELIAL CELL LOSS 1 0.0147
29 CORNEAL GRAFT REJECTION 3 0.0143
30 NECROTISING SCLERITIS 2 0.0138
31 HISTOLOGY ABNORMAL 3 0.0136
32 LIMBAL STEM CELL DEFICIENCY 1 0.0122
33 BLOOD COPPER DECREASED 1 0.0122
34 CHORIORETINAL SCAR 1 0.0120
35 AMOEBIC COLITIS 1 0.0110
36 FALSE POSITIVE LABORATORY RESULT 2 0.0108
37 BRONCHIOLOALVEOLAR CARCINOMA 1 0.0103
38 CILIARY BODY DISORDER 1 0.0101
39 FUNDOSCOPY ABNORMAL 1 0.0096
40 TRICHOPHYTOSIS 2 0.0094
41 HAEMATOLOGY TEST ABNORMAL 3 0.0093
42 CORNEAL INFECTION 2 0.0092
43 GAMMA-GLUTAMYLTRANSFERASE 1 0.0092
44 KL-6 INCREASED 2 0.0088
45 OPTIC DISC OEDEMA 1 0.0086
46 OPTIC NERVE INFARCTION 1 0.0085
47 ASTEATOSIS 1 0.0085
48 PERSISTENT CORNEAL EPITHELIAL DEFECT 1 0.0085
49 CONJUNCTIVAL EROSION 1 0.0083
50 PNEUMONIA HAEMOPHILUS 4 0.0082
51 CATARACT SUBCAPSULAR 5 0.0082
52 OCULAR PEMPHIGOID 1 0.0080
53 ANTERIOR CHAMBER FIBRIN 1 0.0078
54 COLORECTAL CANCER RECURRENT 1 0.0078
55 HAEMOPHILUS TEST POSITIVE 1 0.0078
56 CORNEAL DEFECT 1 0.0076
57 STEATOHEPATITIS 4 0.0075
58 CYTOMEGALOVIRUS CHORIORETINITIS 14 0.0072
59 DERMATOPHYTOSIS 2 0.0070
60 RELAPSING FEVER 2 0.0069
61 GERM CELL CANCER 1 0.0069
62 CORNEAL EPITHELIUM DEFECT 4 0.0069
63 LENTICULAR OPACITIES 3 0.0069
64 DERMATOCHALASIS 1 0.0068
65 CATARACT CORTICAL 1 0.0067
66 PUNCTATE KERATITIS 6 0.0065
67 ECZEMA ASTEATOTIC 3 0.0064
68 MONONEURITIS 1 0.0064
69 MUCOCUTANEOUS DISORDER 1 0.0063
70 KERATITIS BACTERIAL 1 0.0061
71 HAEMOSTASIS 1 0.0061
72 CARNITINE DEFICIENCY 1 0.0058
73 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 2 0.0056
74 PANOPHTHALMITIS 1 0.0055
75 PERSEVERATION 1 0.0054
76 OCULAR HYPERTENSION 10 0.0051
77 CHRONIC PIGMENTED PURPURA 1 0.0051
78 LEUKODERMA 1 0.0050
79 IMPLANTATION COMPLICATION 1 0.0048
80 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
81 OPTIC DISC DISORDER 1 0.0048
82 PERIORBITAL PAIN 4 0.0047
83 INFECTIVE SPONDYLITIS 1 0.0041
84 CORNEAL DEPOSITS 3 0.0040
85 INFECTED NEOPLASM 1 0.0040
86 CORNEAL OEDEMA 9 0.0040
87 CORNEAL SCAR 2 0.0040
88 CORNEAL TRANSPLANT 3 0.0038
89 SKIN BACTERIAL INFECTION 3 0.0037
90 FACIAL WASTING 1 0.0037
91 CYSTOID MACULAR OEDEMA 7 0.0037
92 HYPOPYON 3 0.0036
93 ATOPY 1 0.0036
94 HAEMATOMA EVACUATION 1 0.0035
95 IMMATURE GRANULOCYTE COUNT INCREASED 1 0.0035
96 CARBUNCLE 1 0.0035
97 ENDOPHTHALMITIS 20 0.0033
98 EYE ABSCESS 1 0.0033
99 EPIDERMOLYSIS BULLOSA 1 0.0032
100 MUSCLE ABSCESS 2 0.0032
101 CORNEAL INFILTRATES 1 0.0032
102 RED BLOOD CELL ABNORMALITY 3 0.0031
103 ECTROPION 1 0.0030
104 ACQUIRED OESOPHAGEAL WEB 1 0.0029
105 PERIORBITAL IRRITATION 1 0.0029
106 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
107 FUSARIUM INFECTION 2 0.0029
108 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 1 0.0028
109 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
110 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
111 CATHETER REMOVAL 1 0.0028
112 DYSPLASTIC NAEVUS 1 0.0028
113 HYPERPARATHYROIDISM PRIMARY 1 0.0027
114 RED BLOOD CELL COUNT ABNORMAL 4 0.0027
115 HUMAN HERPESVIRUS 6 INFECTION 5 0.0026
116 MESENTERIC ARTERY THROMBOSIS 1 0.0026
117 CAPILLARY DISORDER 1 0.0026
118 EYE INFECTION FUNGAL 1 0.0026
119 MULTIPLE USE OF SINGLE-USE PRODUCT 14 0.0025
120 CORNEAL DYSTROPHY 1 0.0024
121 OESOPHAGEAL RUPTURE 2 0.0024
122 OTITIS MEDIA CHRONIC 1 0.0024
123 HYPOPITUITARISM 4 0.0023
124 POSTRENAL FAILURE 1 0.0023
125 NECK DEFORMITY 1 0.0023
126 HEPATIC ATROPHY 1 0.0022
127 CIRRHOSIS ALCOHOLIC 1 0.0022
128 ECZEMA HERPETICUM 1 0.0022
129 RETINAL EXUDATES 2 0.0021
130 ESCHERICHIA BACTERAEMIA 5 0.0021
131 LACRIMATION DECREASED 1 0.0021
132 MORPHOEA 1 0.0021
133 DUODENAL STENOSIS 1 0.0021
134 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
135 ECZEMA NUMMULAR 1 0.0020
136 INTRAOCULAR LENS IMPLANT 1 0.0020
137 PRINZMETAL ANGINA 2 0.0020
138 ACQUIRED HAEMOPHILIA 2 0.0020
139 BLEPHARAL PIGMENTATION 1 0.0020
140 LIPIDS INCREASED 4 0.0020
141 IRIS ADHESIONS 1 0.0019
142 INJURY CORNEAL 1 0.0019
143 INTRAOCULAR PRESSURE DECREASED 1 0.0019
144 HYDROCELE 2 0.0019
145 UVEITIS 25 0.0018
146 SUPERFICIAL INJURY OF EYE 2 0.0018
147 TINEA INFECTION 2 0.0018
148 PRODUCT CLOSURE ISSUE 1 0.0018
149 NAIL DYSTROPHY 1 0.0018
150 EYE INFLAMMATION 17 0.0018
151 CYTOMEGALOVIRUS COLITIS 4 0.0017
152 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
153 FOREIGN BODY SENSATION IN EYES 11 0.0017
154 CATATONIA 9 0.0017
155 DEVICE MAINTENANCE ISSUE 1 0.0017
156 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
157 AMBLYOPIA 1 0.0017
158 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
159 RETINAL VASCULITIS 2 0.0017
160 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
161 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
162 OPEN ANGLE GLAUCOMA 1 0.0016
163 VITRITIS 3 0.0016
164 BILIARY TRACT INFECTION 1 0.0016
165 ARTHRITIS REACTIVE 1 0.0016
166 RETINAL OEDEMA 3 0.0016
167 NECROTISING RETINITIS 1 0.0016
168 INFUSION SITE IRRITATION 2 0.0016
169 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
170 BROW PTOSIS 1 0.0015
171 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
172 CATARACT NUCLEAR 1 0.0015
173 CORNEAL OPACITY 2 0.0015
174 CUTANEOUS SYMPTOM 1 0.0015
175 ULCERATIVE KERATITIS 4 0.0015
176 PRERENAL FAILURE 2 0.0014
177 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
178 ANTERIOR CHAMBER CELL 1 0.0014
179 LIP EROSION 1 0.0014
180 CLONIC CONVULSION 1 0.0014
181 OTITIS MEDIA ACUTE 1 0.0014
182 COCCYDYNIA 2 0.0014
183 CONJUNCTIVITIS ALLERGIC 2 0.0013
184 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
185 IMPETIGO 2 0.0013
186 PEMPHIGOID 10 0.0013
187 BRONCHITIS BACTERIAL 1 0.0013
188 MONOCLONAL IMMUNOGLOBULIN PRESENT 1 0.0013
189 ASPIRATION PLEURAL CAVITY 1 0.0013
190 CREATINE KINASE INCREASED 1 0.0013
191 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
192 MYASTHENIC SYNDROME 1 0.0013
193 AORTIC DISORDER 1 0.0013
194 IRIDOCYCLITIS 4 0.0013
195 POLYPECTOMY 1 0.0013
196 BACTERIAL SEPSIS 4 0.0012
197 ANAL ULCER 1 0.0012
198 EYELID IRRITATION 3 0.0012
199 MALIGNANT HYPERTENSION 1 0.0012
200 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
201 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
202 PARONYCHIA 5 0.0011
203 INFUSION SITE DISCOLOURATION 1 0.0011
204 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
205 CERUMEN IMPACTION 1 0.0011
206 IMMUNE-MEDIATED MYOSITIS 3 0.0011
207 TRAUMATIC HAEMORRHAGE 2 0.0011
208 HYPOPROTEINAEMIA 2 0.0011
209 HYPERMETROPIA 1 0.0011
210 OSTEOPOROTIC FRACTURE 2 0.0010
211 EPIDERMAL NECROSIS 1 0.0010
212 EYELID RASH 1 0.0010
213 MASTOIDITIS 1 0.0010
214 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
215 LYMPHOCYTIC INFILTRATION 1 0.0010
216 BLINDNESS UNILATERAL 14 0.0010
217 DERMATITIS ACNEIFORM 6 0.0010
218 PNEUMONIA BACTERIAL 9 0.0010
219 FULMINANT TYPE 1 DIABETES MELLITUS 1 0.0010
220 INFUSION SITE PRURITUS 3 0.0009
221 INTRAOCULAR PRESSURE INCREASED 12 0.0009
222 SKIN EROSION 3 0.0009
223 KETOSIS 1 0.0009
224 ACARODERMATITIS 1 0.0009
225 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
226 EYE PAIN 51 0.0009
227 PERIRECTAL ABSCESS 1 0.0009
228 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
229 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
230 CARBON DIOXIDE DECREASED 1 0.0009
231 ENTEROCOLITIS 5 0.0009
232 SINUS PAIN 2 0.0009
233 PUSTULE 2 0.0008
234 PNEUMONIA INFLUENZAL 1 0.0008
235 INFUSION SITE WARMTH 1 0.0008
236 ORAL MUCOSA EROSION 1 0.0008
237 OCULAR DISCOMFORT 9 0.0008
238 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
239 PHOTOPHOBIA 15 0.0008
240 REBOUND EFFECT 9 0.0008
241 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
242 NOCARDIOSIS 2 0.0008
243 ASPERGILLOSIS 1 0.0008
244 HERPES OPHTHALMIC 1 0.0008
245 ACROCHORDON 1 0.0008
246 BLEPHARITIS 3 0.0007
247 EFFUSION 1 0.0007
248 CORNEAL ABRASION 1 0.0007
249 IMMUNOGLOBULINS DECREASED 1 0.0007
250 MYELITIS TRANSVERSE 1 0.0007
251 EYE INFECTION 8 0.0007
252 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
253 AUDITORY DISORDER 1 0.0007
254 CEREBELLAR HAEMORRHAGE 1 0.0007
255 MENINGITIS BACTERIAL 1 0.0007
256 POST HERPETIC NEURALGIA 1 0.0007
257 RHEUMATOID FACTOR POSITIVE 4 0.0007
258 ESCHERICHIA SEPSIS 2 0.0007
259 MUTISM 1 0.0007
260 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
261 LUMBAR SPINAL STENOSIS 2 0.0007
262 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
263 INFUSION SITE INDURATION 1 0.0007
264 HEPATITIS FULMINANT 2 0.0007
265 CATARACT OPERATION 4 0.0007
266 HYPERTHERMIA MALIGNANT 1 0.0007
267 PRODUCT AVAILABILITY ISSUE 15 0.0007
268 KERATITIS 2 0.0007
269 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
270 ERYTHEMA MULTIFORME 6 0.0006
271 OSTEOSCLEROSIS 1 0.0006
272 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
273 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
274 EYE IRRITATION 36 0.0006
275 GLAUCOMA 12 0.0006
276 CYSTITIS INTERSTITIAL 1 0.0006
277 COLON CANCER METASTATIC 1 0.0006
278 RENAL CELL CARCINOMA 3 0.0006
279 DEAFNESS NEUROSENSORY 2 0.0006
280 CEREBELLAR INFARCTION 1 0.0006
281 BLOOD AMYLASE INCREASED 1 0.0006
282 BLOOD CHLORIDE INCREASED 1 0.0006
283 ADRENAL INSUFFICIENCY 7 0.0006
284 OTORRHOEA 1 0.0006
285 MENINGITIS CRYPTOCOCCAL 1 0.0006
286 INFUSION SITE DISCHARGE 1 0.0006
287 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
288 PANCREATIC FAILURE 1 0.0006
289 CONJUNCTIVAL HYPERAEMIA 2 0.0006
290 SPONDYLITIS 2 0.0005
291 ESSENTIAL HYPERTENSION 1 0.0005
292 CONTRAST MEDIA ALLERGY 1 0.0005
293 ASTHENOPIA 3 0.0005
294 METAMORPHOPSIA 1 0.0005
295 DISORGANISED SPEECH 1 0.0005
296 HYPERTRICHOSIS 1 0.0005
297 RETINOPATHY 2 0.0005
298 MACULAR OEDEMA 3 0.0005
299 BLADDER SPASM 1 0.0005
300 IMPATIENCE 1 0.0005
301 PROTEIN TOTAL DECREASED 2 0.0005
302 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
303 BLOOD URIC ACID INCREASED 3 0.0005
304 MOTION SICKNESS 1 0.0005
305 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
306 ATROPHY 1 0.0005
307 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
308 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
309 JOINT NOISE 1 0.0005
310 DRUG ERUPTION 9 0.0005
311 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
312 BLOOD ALBUMIN DECREASED 4 0.0005
313 TRANSPLANT REJECTION 4 0.0005
314 HYPOPHYSITIS 1 0.0005
315 EYELID PAIN 1 0.0005
316 DEVICE DEPOSIT ISSUE 1 0.0005
317 IMMUNE-MEDIATED HEPATITIS 1 0.0005
318 ARTHRITIS BACTERIAL 2 0.0005
319 ANAPHYLACTOID REACTION 2 0.0005
320 PIGMENTATION DISORDER 3 0.0005
321 CHOLANGITIS 3 0.0005
322 SPINAL COMPRESSION FRACTURE 4 0.0005
323 EYE DISCHARGE 5 0.0005
324 SWELLING OF EYELID 3 0.0005
325 LATENT TUBERCULOSIS 1 0.0005
326 ATRIAL TACHYCARDIA 1 0.0005
327 DILATATION VENTRICULAR 1 0.0005
328 NEUROGENIC BLADDER 1 0.0005
329 ANAEMIA MACROCYTIC 1 0.0005
330 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
331 ABNORMAL SENSATION IN EYE 2 0.0005
332 PARANOIA 8 0.0005
333 OCULAR HYPERAEMIA 22 0.0005
334 INFUSION SITE BRUISING 1 0.0005
335 PERIODONTITIS 1 0.0005
336 PYELONEPHRITIS 4 0.0005
337 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
338 MIDDLE EAR EFFUSION 1 0.0005
339 TRANSAMINASES INCREASED 10 0.0004
340 BACTERIAL TEST POSITIVE 1 0.0004
341 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
342 SUSPECTED OFF LABEL USE 2 0.0004
343 VASCULAR DEVICE INFECTION 2 0.0004
344 HAEMATOCRIT INCREASED 1 0.0004
345 LUMBAR VERTEBRAL FRACTURE 2 0.0004
346 EYE OPERATION 2 0.0004
347 LICHEN PLANUS 1 0.0004
348 LACRIMATION INCREASED 13 0.0004
349 SKIN ABRASION 2 0.0004
350 RETINAL HAEMORRHAGE 3 0.0004
351 EOSINOPHIL COUNT DECREASED 1 0.0004
352 DIABETES INSIPIDUS 1 0.0004
353 LYMPHADENITIS 1 0.0004
354 HAEMATOLOGICAL INFECTION 1 0.0004
355 EYE OEDEMA 1 0.0004
356 ENCEPHALOPATHY 10 0.0004
357 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
358 DEVICE INFUSION ISSUE 1 0.0004
359 INJECTION SITE ABSCESS 1 0.0004
360 INFREQUENT BOWEL MOVEMENTS 1 0.0004
361 PROTEIN URINE PRESENT 2 0.0004
362 MEAN CELL VOLUME INCREASED 1 0.0004
363 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
364 PHYSICAL DECONDITIONING 1 0.0004
365 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
366 OSTEOMYELITIS 7 0.0004
367 CATARACT 23 0.0004
368 LIPOMA 1 0.0004
369 HYPOALBUMINAEMIA 3 0.0004
370 CATHETER SITE PAIN 1 0.0004
371 COMPARTMENT SYNDROME 1 0.0004
372 LUNG OPACITY 1 0.0004
373 COMPRESSION FRACTURE 2 0.0004
374 PRODUCT DELIVERY MECHANISM ISSUE 2 0.0004
375 BLOOD SODIUM INCREASED 1 0.0004
376 HYPERKERATOSIS 2 0.0004
377 PRODUCT LEAKAGE 2 0.0004
378 NEPHROPATHY TOXIC 4 0.0004
379 INFUSION SITE ERYTHEMA 3 0.0004
380 NEUTROPHIL COUNT ABNORMAL 1 0.0004
381 PSEUDOMONAS INFECTION 3 0.0003
382 FIBULA FRACTURE 1 0.0003
383 DEVICE DEFECTIVE 6 0.0003
384 HAEMOTHORAX 1 0.0003
385 TUMOUR LYSIS SYNDROME 3 0.0003
386 INFUSION SITE REACTION 1 0.0003
387 LUNG ADENOCARCINOMA 1 0.0003
388 IRITIS 1 0.0003
389 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
390 GENERALISED OEDEMA 4 0.0003
391 EYE SWELLING 12 0.0003
392 NEPHROPATHY 3 0.0003
393 THERAPY PARTIAL RESPONDER 5 0.0003
394 PRE-EXISTING CONDITION IMPROVED 2 0.0003
395 BLINDNESS 13 0.0003
396 EOSINOPHILIC PNEUMONIA 1 0.0003
397 RECALLED PRODUCT ADMINISTERED 3 0.0003
398 PNEUMONIA VIRAL 1 0.0003
399 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
400 CUSHINGOID 1 0.0003
401 LIVER ABSCESS 1 0.0003
402 POSTURE ABNORMAL 1 0.0003
403 NEPHRITIS 1 0.0003
404 POTENTIATING DRUG INTERACTION 1 0.0003
405 TOXIC SKIN ERUPTION 3 0.0003
406 NEOPLASM RECURRENCE 1 0.0003
407 PRODUCT LABEL ISSUE 2 0.0003
408 NEUTROPHIL COUNT DECREASED 12 0.0003
409 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
410 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
411 CERVICAL VERTEBRAL FRACTURE 1 0.0003
412 ENCEPHALITIS 2 0.0003
413 LARGE INTESTINE POLYP 2 0.0003
414 HYPERTRANSAMINASAEMIA 2 0.0003
415 CEREBRAL INFARCTION 7 0.0003
416 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
417 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
418 LIVER FUNCTION TEST INCREASED 6 0.0003
419 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
420 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
421 AMYLASE INCREASED 1 0.0003
422 STEVENS-JOHNSON SYNDROME 6 0.0003
423 INTESTINAL PERFORATION 3 0.0003
424 CHRONIC SINUSITIS 1 0.0003
425 PARANASAL SINUS DISCOMFORT 1 0.0003
426 LOSS OF CONTROL OF LEGS 1 0.0003
427 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
428 POST PROCEDURAL COMPLICATION 5 0.0003
429 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
430 APHTHOUS ULCER 2 0.0003
431 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
432 CERVIX CARCINOMA 1 0.0003
433 PRODUCT USE COMPLAINT 4 0.0003
434 OESOPHAGEAL CANDIDIASIS 1 0.0003
435 FOREIGN BODY 1 0.0002
436 DECUBITUS ULCER 2 0.0002
437 GOITRE 1 0.0002
438 HYPERURICAEMIA 1 0.0002
439 EYE DISORDER 8 0.0002
440 VISUAL ACUITY REDUCED 8 0.0002
441 INTESTINAL STENOSIS 1 0.0002
442 SKIN PLAQUE 2 0.0002
443 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
444 ABSCESS LIMB 1 0.0002
445 FACIAL PARALYSIS 2 0.0002
446 SKIN HYPERPIGMENTATION 2 0.0002
447 HORDEOLUM 1 0.0002
448 MONOPLEGIA 1 0.0002
449 BLOOD CALCIUM INCREASED 2 0.0002
450 SPINAL OSTEOARTHRITIS 2 0.0002
451 INTERSTITIAL LUNG DISEASE 11 0.0002
452 IMMUNOSUPPRESSION 2 0.0002
453 BLOOD CREATINE INCREASED 1 0.0002
454 FACIAL PAIN 2 0.0002
455 PNEUMONITIS 6 0.0002
456 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
457 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
458 EAR DISORDER 1 0.0002
459 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
460 ARTHRITIS INFECTIVE 1 0.0002
461 HYPOMAGNESAEMIA 3 0.0002
462 PERFORMANCE STATUS DECREASED 1 0.0002
463 LACERATION 2 0.0002
464 ENDOMETRIOSIS 1 0.0002
465 ATELECTASIS 2 0.0002
466 FINGER DEFORMITY 1 0.0002
467 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
468 VISION BLURRED 28 0.0002
469 EXPIRED DRUG ADMINISTERED 1 0.0002
470 ORGANISING PNEUMONIA 1 0.0002
471 DELIRIUM 7 0.0002
472 HYPERNATRAEMIA 1 0.0002
473 HEPATIC ENZYME ABNORMAL 1 0.0002
474 DERMATITIS EXFOLIATIVE 1 0.0002
475 ERYSIPELAS 1 0.0002
476 DYSLIPIDAEMIA 1 0.0002
477 EYELID PTOSIS 2 0.0002
478 AMMONIA INCREASED 1 0.0002
479 FEMORAL NECK FRACTURE 1 0.0002
480 ENDOCARDITIS 1 0.0002
481 DEVICE RELATED INFECTION 3 0.0002
482 EJECTION FRACTION DECREASED 3 0.0002
483 DERMATITIS 4 0.0002
484 POLYARTHRITIS 1 0.0002
485 HEPATIC FUNCTION ABNORMAL 7 0.0002
486 ANAL FISTULA 1 0.0002
487 INJECTION SITE DISCHARGE 1 0.0002
488 GINGIVITIS 1 0.0002
489 CHEILITIS 1 0.0002
490 ERYTHEMA OF EYELID 1 0.0002
491 PRODUCT PRESCRIBING ISSUE 4 0.0002
492 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
493 MENTAL STATUS CHANGES 5 0.0002
494 HEART RATE ABNORMAL 1 0.0002
495 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
496 ANGIOPATHY 1 0.0002
497 THERAPY NON-RESPONDER 8 0.0002
498 PERIORBITAL SWELLING 1 0.0002
499 NEUTROPHILIA 1 0.0002
500 DERMATITIS CONTACT 2 0.0002
501 HALLUCINATION 13 0.0002
502 EYELID OEDEMA 2 0.0002
503 HYPERTRIGLYCERIDAEMIA 1 0.0002
504 PSYCHOTIC DISORDER 5 0.0002
505 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
506 BACTERAEMIA 2 0.0002
507 HEPATITIS B 1 0.0002
508 GANGRENE 1 0.0002
509 STOMATITIS 10 0.0002
510 TREATMENT NONCOMPLIANCE 9 0.0002
511 PLEURAL EFFUSION 10 0.0002
512 CARDIOMEGALY 2 0.0002
513 PHARYNGITIS 2 0.0002
514 LEUKOPENIA 8 0.0002
515 INFUSION SITE SWELLING 1 0.0002
516 PHOTOPSIA 1 0.0002
517 ENTERITIS 1 0.0002
518 SKIN ULCER 4 0.0002
519 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
520 SKIN FISSURES 3 0.0002
521 VISUAL IMPAIRMENT 19 0.0002
522 BRADYPHRENIA 1 0.0002
523 HYPOGAMMAGLOBULINAEMIA 1 0.0002
524 ORAL CANDIDIASIS 2 0.0002
525 IMMUNE SYSTEM DISORDER 2 0.0002
526 MENINGITIS 1 0.0001
527 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
528 EYE PRURITUS 5 0.0001
529 PRODUCT ADMINISTRATION ERROR 3 0.0001
530 SINUS CONGESTION 2 0.0001
531 TASTE DISORDER 3 0.0001
532 ABNORMAL LOSS OF WEIGHT 1 0.0001
533 BLOOD TESTOSTERONE DECREASED 1 0.0001
534 EYE MOVEMENT DISORDER 1 0.0001
535 ECCHYMOSIS 1 0.0001
536 HAIR GROWTH ABNORMAL 1 0.0001
537 LARGE INTESTINE PERFORATION 1 0.0001
538 PAPULE 1 0.0001
539 DUODENAL ULCER 1 0.0001
540 HAND FRACTURE 1 0.0001
541 DRY EYE 7 0.0001
542 BLOOD CREATININE INCREASED 9 0.0001
543 C-REACTIVE PROTEIN INCREASED 5 0.0001
544 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
545 BLINDNESS TRANSIENT 1 0.0001
546 PANCREATITIS ACUTE 3 0.0001
547 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
548 HEPATIC FAILURE 4 0.0001
549 HEPATIC ENZYME INCREASED 9 0.0001
550 ANKLE FRACTURE 2 0.0001
551 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
552 DRUG-INDUCED LIVER INJURY 4 0.0001
553 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
554 FURUNCLE 1 0.0001
555 RESPIRATORY TRACT CONGESTION 2 0.0001
556 BLISTER 7 0.0001
557 DRUG INTOLERANCE 12 0.0001
558 MYASTHENIA GRAVIS 1 0.0001
559 FRUSTRATION TOLERANCE DECREASED 1 0.0001
560 LIVER INJURY 3 0.0001
561 ABNORMAL FAECES 1 0.0001
562 METASTASES TO BONE 2 0.0001
563 HYPERAESTHESIA 1 0.0001
564 HAIR DISORDER 1 0.0001
565 FEBRILE NEUTROPENIA 8 0.0001
566 DECREASED APPETITE 28 0.0001
567 EXPIRED PRODUCT ADMINISTERED 4 0.0001
568 CYTOMEGALOVIRUS INFECTION 2 0.0001
569 SKIN DISORDER 4 0.0001
570 URINARY RETENTION 4 0.0001
571 BLOOD UREA INCREASED 2 0.0001
572 FACE OEDEMA 2 0.0001
573 GASTRIC CANCER 3 0.0001
574 DRUG RESISTANCE 3 0.0001
575 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
576 NO ADVERSE EVENT 21 0.0001
577 BLOOD MAGNESIUM DECREASED 1 0.0001
578 RASH GENERALISED 3 0.0001
579 CARDIAC MURMUR 1 0.0001
580 DEVICE USE ISSUE 2 0.0001
581 METASTASES TO LIVER 2 0.0001
582 HYPOXIA 4 0.0001
583 LUNG INFILTRATION 1 0.0001
584 LYMPHOCYTE COUNT DECREASED 2 0.0001
585 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
586 LIVER DISORDER 5 0.0001
587 HAEMOLYTIC ANAEMIA 1 0.0001
588 MYOSITIS 1 0.0001
589 BLOOD BILIRUBIN INCREASED 3 0.0001
590 LEUKOCYTOSIS 2 0.0001
591 TOOTHACHE 2 0.0001
592 OPTIC NEURITIS 1 0.0001
593 HYPERGLYCAEMIA 4 0.0001
594 PATHOGEN RESISTANCE 1 0.0001
595 IRON DEFICIENCY ANAEMIA 1 0.0001
596 HYPOKALAEMIA 5 0.0001
597 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
598 SWELLING FACE 7 0.0001
599 HEPATIC ENCEPHALOPATHY 1 0.0001
600 APPENDICITIS 1 0.0001
601 DEFORMITY 1 0.0001
602 SKIN EXFOLIATION 9 0.0001
603 HYPONATRAEMIA 6 0.0001
604 ARTERIOSCLEROSIS 1 0.0001
605 LEUKAEMIA 1 0.0001
606 HYPOCALCAEMIA 2 0.0001
607 RED BLOOD CELL COUNT DECREASED 3 0.0001
608 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
609 HERPES ZOSTER 6 0.0001
610 PLATELET COUNT DECREASED 11 0.0001
611 DIZZINESS POSTURAL 1 0.0001
612 AUTOIMMUNE DISORDER 1 0.0001
613 LABORATORY TEST ABNORMAL 3 0.0001
614 URINARY INCONTINENCE 3 0.0001
615 BLOOD POTASSIUM DECREASED 3 0.0001
616 CELLULITIS 5 0.0001
617 DEVICE BREAKAGE 4 0.0001
618 DRY THROAT 1 0.0001
619 DRUG LEVEL DECREASED 1 0.0001
620 ACUTE KIDNEY INJURY 15 0.0001
621 THERAPY INTERRUPTED 7 0.0001
622 NEUTROPHIL COUNT INCREASED 1 0.0001
623 EAR DISCOMFORT 1 0.0001
624 RIB FRACTURE 2 0.0001
625 INFLAMMATION 5 0.0001
626 POOR VENOUS ACCESS 1 0.0001
627 HYPERBILIRUBINAEMIA 1 0.0001
628 PULMONARY HYPERTENSION 2 0.0001
629 MOUTH ULCERATION 2 0.0001
630 INCONTINENCE 1 0.0001
631 HYPOTHYROIDISM 3 0.0001
632 EPISTAXIS 7 0.0001
633 MOVEMENT DISORDER 3 0.0001
634 HOT FLUSH 7 0.0001
635 DECREASED ACTIVITY 1 0.0001
636 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
637 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
638 OEDEMA 5 0.0001
639 BACK INJURY 1 0.0001
640 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
641 ASPIRATION 1 0.0001
642 MELAENA 2 0.0001
643 DENTAL CARIES 1 0.0001
644 BLOOD PRESSURE DECREASED 6 0.0001
645 FOOT DEFORMITY 1 0.0001
646 NERVE INJURY 1 0.0001
647 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
648 ORAL PAIN 2 0.0001
649 RASH PAPULAR 2 0.0001
650 SNEEZING 2 0.0001
651 FISTULA 1 0.0001
652 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
653 MYOCARDIAL ISCHAEMIA 1 0.0001
654 MYOCARDITIS 1 0.0001
655 CARDIAC FAILURE 7 0.0001
656 DRY MOUTH 7 0.0001
657 MADAROSIS 1 0.0001
658 ELECTROLYTE IMBALANCE 1 0.0001
659 RENAL DISORDER 4 0.0001
660 HYPERKALAEMIA 3 0.0001
661 SLEEP DISORDER 6 0.0001
662 WEIGHT INCREASED 19 0.0001
663 COVID-19 PNEUMONIA 1 0.0001
664 DISEASE PROGRESSION 10 0.0001
665 ATAXIA 1 0.0001
666 DISEASE RECURRENCE 4 0.0001
667 CEREBRAL HAEMORRHAGE 3 0.0001
668 MACULAR DEGENERATION 1 0.0001
669 HYPERLIPIDAEMIA 1 0.0001
670 MUSCLE RIGIDITY 1 0.0001
671 POLYNEUROPATHY 1 0.0001
672 DIABETIC KETOACIDOSIS 2 0.0001
673 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
674 BURSITIS 1 0.0001
675 URINARY TRACT INFECTION 14 0.0001
676 OEDEMA PERIPHERAL 10 0.0001
677 AGITATION 6 0.0001
678 HYPERCALCAEMIA 1 0.0001
679 ILEUS 1 0.0001
680 PNEUMONIA ASPIRATION 2 0.0001
681 MUSCULOSKELETAL STIFFNESS 7 0.0001
682 HYPOPHAGIA 2 0.0001
683 PRODUCT DOSE OMISSION ISSUE 23 0.0001
684 HAEMOGLOBIN DECREASED 8 0.0001
685 INFUSION SITE PAIN 1 0.0001
686 HIATUS HERNIA 1 0.0001
687 HAEMATOMA 2 0.0001
688 INJECTION SITE INDURATION 1 0.0001
689 BEDRIDDEN 1 0.0001
690 INFECTION 11 0.0001
691 EAR INFECTION 2 0.0001
692 EYE HAEMORRHAGE 1 0.0001
693 MALIGNANT MELANOMA 1 0.0001
694 NEUROPATHY PERIPHERAL 7 0.0001
695 IMPAIRED GASTRIC EMPTYING 1 0.0001
696 ACUTE HEPATIC FAILURE 1 0.0001
697 LUNG NEOPLASM MALIGNANT 3 0.0001
698 CORONARY ARTERY OCCLUSION 1 0.0001
699 PERIPHERAL COLDNESS 1 0.0001
700 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
701 RESPIRATORY DISTRESS 2 0.0001
702 PROCEDURAL PAIN 2 0.0001
703 POLLAKIURIA 3 0.0001
704 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
705 CARDIO-RESPIRATORY ARREST 3 0.0001
706 DEMENTIA 2 0.0001
707 MASS 1 0.0001
708 BLOOD TEST ABNORMAL 1 0.0001
709 DEVICE OCCLUSION 1 0.0001
710 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
711 LYMPHOPENIA 1 0.0001
712 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
713 PARALYSIS 1 0.0001
714 ANGINA PECTORIS 2 0.0001
715 IMPAIRED QUALITY OF LIFE 1 0.0001
716 ANOSMIA 1 0.0001
717 CONDITION AGGRAVATED 21 0.0001
718 FLUID OVERLOAD 1 0.0001
719 NEEDLE ISSUE 2 0.0001
720 INTENTIONAL PRODUCT MISUSE 6 0.0001
721 GASTROENTERITIS 1 0.0001
722 ERYTHEMA 14 0.0001
723 ASCITES 2 0.0001
724 CARDIOMYOPATHY 1 0.0001
725 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
726 OFF LABEL USE 59 0.0001
727 IMMUNODEFICIENCY 1 0.0001
728 HYPOAESTHESIA ORAL 1 0.0001
729 APHASIA 2 0.0001
730 CORONARY ARTERY DISEASE 2 0.0001
731 OSTEOPENIA 1 0.0001
732 DEVICE FAILURE 1 0.0001
733 DRUG DISPENSING ERROR 1 0.0001
734 LUNG INFECTION 1 0.0001
735 BLOOD CHOLESTEROL INCREASED 3 0.0001
736 BASAL CELL CARCINOMA 1 0.0001
737 PNEUMOTHORAX 1 0.0001
738 HALLUCINATION, AUDITORY 1 0.0001
739 ANAEMIA 12 0.0001
740 OBESITY 1 0.0001
741 SEPSIS 7 0.0001
742 RHINORRHOEA 4 0.0001
743 BLOOD POTASSIUM INCREASED 1 0.0001
744 IMPAIRED HEALING 2 0.0001
745 PYREXIA 21 0.0001
746 STAPHYLOCOCCAL INFECTION 2 0.0001
747 DRUG LEVEL INCREASED 1 0.0001
748 TREATMENT FAILURE 5 0.0001
749 VIRAL INFECTION 2 0.0001
750 DEHYDRATION 8 0.0001
751 GAIT INABILITY 2 0.0001
752 PERICARDITIS 1 0.0001
753 RENAL IMPAIRMENT 5 0.0001
754 ANGER 2 0.0001
755 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
756 BLOOD GLUCOSE INCREASED 11 0.0001
757 ILLNESS 6 0.0001
758 DRUG INEFFECTIVE 76 0.0001
759 ORTHOSTATIC HYPOTENSION 1 0.0001
760 EOSINOPHILIA 1 0.0001
761 COVID-19 10 0.0001
762 DERMATITIS ATOPIC 3 0.0001
763 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
764 BRADYCARDIA 3 0.0001
765 LYMPHADENOPATHY 2 0.0001
766 HEAD DISCOMFORT 1 0.0001
767 BACK PAIN 13 0.0001
768 DEVICE ISSUE 5 0.0001
769 GOUT 1 0.0001
770 MYELOSUPPRESSION 2 0.0001
771 RASH PRURITIC 3 0.0001
772 RASH 24 0.0001
773 BONE DISORDER 1 0.0001
774 END STAGE RENAL DISEASE 1 0.0001
775 MALAISE 24 0.0001
776 ACCIDENTAL OVERDOSE 2 0.0001
777 HAEMATOCHEZIA 3 0.0001
778 DYSURIA 2 0.0001
779 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
780 CONJUNCTIVITIS 1 0.0001
781 DYSGEUSIA 4 0.0001
782 PANCYTOPENIA 3 0.0001
783 BACTERIAL INFECTION 1 0.0001
784 DYSARTHRIA 2 0.0001
785 DYSPNOEA EXERTIONAL 2 0.0001
786 FRACTURE 1 0.0001
787 COLITIS 2 0.0001
788 ACNE 4 0.0001
789 FOOT FRACTURE 1 0.0001
790 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
791 CHOLESTASIS 1 0.0001
792 LOWER LIMB FRACTURE 1 0.0001
793 ACUTE RESPIRATORY FAILURE 1 0.0001
794 PRESCRIBED OVERDOSE 1 0.0001
795 NEUTROPENIA 7 0.0001
796 HAEMORRHOIDS 1 0.0001
797 FALL 17 0.0001
798 NASAL CONGESTION 3 0.0001
799 HEADACHE 32 0.0001
800 KIDNEY INFECTION 1 0.0001
801 ARTHRITIS 4 0.0001
802 PRESCRIBED UNDERDOSE 1 0.0001
803 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
804 CYTOKINE RELEASE SYNDROME 1 0.0000
805 FULL BLOOD COUNT DECREASED 1 0.0000
806 DIARRHOEA 32 0.0000
807 PNEUMONIA 16 0.0000
808 FEEDING DISORDER 1 0.0000
809 DYSKINESIA 2 0.0000
810 BONE MARROW FAILURE 1 0.0000
811 OSTEOPOROSIS 2 0.0000
812 HALLUCINATION, VISUAL 1 0.0000
813 OSTEOARTHRITIS 2 0.0000
814 PRODUCT STORAGE ERROR 4 0.0000
815 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
816 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
817 DRY SKIN 6 0.0000
818 HEPATOTOXICITY 1 0.0000
819 INFLUENZA 5 0.0000
820 THROMBOCYTOPENIA 5 0.0000
821 CHROMATURIA 1 0.0000
822 ASTHMA 5 0.0000
823 PRURITUS 17 0.0000
824 NEPHROLITHIASIS 2 0.0000
825 TINNITUS 2 0.0000
826 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
827 OROPHARYNGEAL PAIN 4 0.0000
828 SWELLING 4 0.0000
829 PALPITATIONS 5 0.0000
830 RASH ERYTHEMATOUS 2 0.0000
831 BLOOD PRESSURE FLUCTUATION 1 0.0000
832 PRESYNCOPE 1 0.0000
833 NEURALGIA 1 0.0000
834 FATIGUE 32 0.0000
835 ATRIAL FIBRILLATION 4 0.0000
836 ALOPECIA 8 0.0000
837 OSTEONECROSIS OF JAW 1 0.0000
838 AGEUSIA 1 0.0000
839 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
840 HAEMATEMESIS 1 0.0000
841 DIABETES MELLITUS 3 0.0000
842 BLOOD PRESSURE INCREASED 6 0.0000
843 HEPATITIS 1 0.0000
844 SINUSITIS 4 0.0000
845 EXPOSURE VIA SKIN CONTACT 1 0.0000
846 DIPLOPIA 1 0.0000
847 DEAFNESS 1 0.0000
848 MUSCULOSKELETAL PAIN 2 0.0000
849 CHEST PAIN 7 0.0000
850 FEAR 1 0.0000
851 PAIN OF SKIN 1 0.0000
852 LIMB INJURY 1 0.0000
853 MOOD ALTERED 1 0.0000
854 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
855 INFLUENZA LIKE ILLNESS 3 0.0000
856 ANAPHYLACTIC REACTION 2 0.0000
857 DIVERTICULITIS 1 0.0000
858 HAEMOPTYSIS 1 0.0000
859 NECK PAIN 2 0.0000
860 PAIN IN JAW 1 0.0000
861 FLATULENCE 2 0.0000
862 RHEUMATOID ARTHRITIS 4 0.0000
863 INTENTIONAL DOSE OMISSION 1 0.0000
864 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
865 PRODUCT SUBSTITUTION ISSUE 2 0.0000
866 PANCREATIC CARCINOMA 1 0.0000
867 ASTHENIA 13 0.0000
868 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
869 DYSSTASIA 1 0.0000
870 WHEEZING 2 0.0000
871 HYPERTENSION 7 0.0000
872 NAUSEA 26 0.0000
873 EPILEPSY 1 0.0000
874 DRUG ADMINISTRATION ERROR 1 0.0000
875 LIMB DISCOMFORT 1 0.0000
876 FEMUR FRACTURE 1 0.0000
877 WEIGHT DECREASED 9 0.0000
878 PRODUCT USE ISSUE 6 0.0000
879 BONE DENSITY DECREASED 1 0.0000
880 PULMONARY EMBOLISM 3 0.0000
881 MIGRAINE 3 0.0000
882 LOSS OF CONSCIOUSNESS 4 0.0000
883 HIP FRACTURE 1 0.0000
884 NIGHT SWEATS 1 0.0000
885 LACTIC ACIDOSIS 1 0.0000
886 DEEP VEIN THROMBOSIS 2 0.0000
887 DEPRESSION 7 0.0000
888 DYSPEPSIA 3 0.0000
889 OSTEONECROSIS 1 0.0000
890 HEART RATE INCREASED 3 0.0000
891 DEVICE DIFFICULT TO USE 2 0.0000
892 INFUSION RELATED REACTION 2 0.0000
893 TREMOR 5 0.0000
894 NEOPLASM MALIGNANT 2 0.0000
895 FLUSHING 3 0.0000
896 HAEMATURIA 1 0.0000
897 ABDOMINAL PAIN UPPER 6 0.0000
898 DEVICE USE ERROR 1 0.0000
899 BURNING SENSATION 2 0.0000
900 INJURY 2 0.0000
901 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
902 DIZZINESS 14 0.0000
903 PRODUCT ADHESION ISSUE 1 0.0000
904 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
905 VOMITING 13 0.0000
906 CONSTIPATION 6 0.0000
907 NASOPHARYNGITIS 5 0.0000
908 HYPERSENSITIVITY 5 0.0000
909 INTESTINAL OBSTRUCTION 1 0.0000
910 PAIN 16 0.0000
911 SEIZURE 3 0.0000
912 CHILLS 3 0.0000
913 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
914 INJECTION SITE BRUISING 2 0.0000
915 INJECTION SITE HAEMORRHAGE 2 0.0000
916 FEELING ABNORMAL 6 0.0000
917 PROSTATE CANCER 2 0.0000
918 JOINT SWELLING 3 0.0000
919 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
920 EXTRA DOSE ADMINISTERED 1 0.0000
921 CARDIAC ARREST 2 0.0000
922 DRUG DOSE OMISSION 4 0.0000
923 INJECTION SITE ERYTHEMA 3 0.0000
924 URTICARIA 4 0.0000
925 ABDOMINAL DISCOMFORT 4 0.0000
926 HYPERHIDROSIS 3 0.0000
927 BALANCE DISORDER 2 0.0000
928 DEVICE LEAKAGE 1 0.0000
929 DEVICE DISLOCATION 1 0.0000
930 MENTAL DISORDER 1 0.0000
931 RENAL FAILURE 3 0.0000
932 INSOMNIA 6 0.0000
933 TACHYCARDIA 2 0.0000
934 COLITIS ULCERATIVE 1 0.0000
935 GASTROINTESTINAL DISORDER 2 0.0000
936 MEMORY IMPAIRMENT 3 0.0000
937 COGNITIVE DISORDER 1 0.0000
938 COUGH 6 0.0000
939 COLORECTAL CANCER 1 0.0000
940 BLOOD GLUCOSE DECREASED 1 0.0000
941 HYPOGLYCAEMIA 1 0.0000
942 LUNG DISORDER 1 0.0000
943 PAIN IN EXTREMITY 6 0.0000
944 HYPOAESTHESIA 3 0.0000
945 SOMNOLENCE 4 0.0000
946 FLUID RETENTION 1 0.0000
947 CHEST DISCOMFORT 2 0.0000
948 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
949 ARTHRALGIA 8 0.0000
950 ECZEMA 1 0.0000
951 PARAESTHESIA 3 0.0000
952 PANCREATITIS 1 0.0000
953 DRUG EFFECT DECREASED 1 0.0000
954 DISTURBANCE IN ATTENTION 1 0.0000
955 OXYGEN SATURATION DECREASED 1 0.0000
956 CEREBROVASCULAR ACCIDENT 3 0.0000
957 DYSPNOEA 10 0.0000
958 MYALGIA 3 0.0000
959 MUSCULAR WEAKNESS 2 0.0000
960 ANXIETY 5 0.0000
961 INCORRECT DOSE ADMINISTERED 4 0.0000
962 BLADDER CANCER 1 0.0000
963 IRRITABILITY 1 0.0000
964 EMOTIONAL DISTRESS 2 0.0000
965 ILL-DEFINED DISORDER 1 0.0000
966 MUSCLE SPASMS 3 0.0000
967 FEELING HOT 1 0.0000
968 GAIT DISTURBANCE 3 0.0000
969 AMNESIA 1 0.0000
970 PSORIASIS 2 0.0000
971 HYPOTENSION 3 0.0000
972 INJECTION SITE PRURITUS 1 0.0000
973 DEVICE MALFUNCTION 1 0.0000
974 MOBILITY DECREASED 1 0.0000
975 BRONCHITIS 1 0.0000
976 CHRONIC KIDNEY DISEASE 1 0.0000
977 INJECTION SITE SWELLING 1 0.0000
978 HOSPITALISATION 2 0.0000
979 PERIPHERAL SWELLING 2 0.0000
980 DEATH 11 0.0000
981 CARDIAC FAILURE CONGESTIVE 1 0.0000
982 CONFUSIONAL STATE 2 0.0000
983 MYOCARDIAL INFARCTION 2 0.0000
984 ADVERSE DRUG REACTION 1 0.0000
985 CARDIAC DISORDER 1 0.0000
986 DYSPHAGIA 1 0.0000
987 CONTUSION 1 0.0000
988 ABDOMINAL DISTENSION 1 0.0000
989 OVERDOSE 2 0.0000
990 INJECTION SITE PAIN 2 0.0000
991 DRUG INTERACTION 1 0.0000
992 ABDOMINAL PAIN 1 0.0000